Study on the role of alcohol intolerance in malignant tumor with cardiovascular and cerebrovascular diseases or metabolic diseases

Study on the role of alcohol intolerance in malignant tumor complicated with cardiovascular and cerebrovascular diseases or metabolic diseases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032636

Enrollment

Unknown

Registered

2020-05-04

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer complicated with cardiovascular and cerebrovascular diseases or metabolic diseases

Interventions

Malignant tumor with cardio cerebrovascular disease or metabolic disease group:N/A

Long-term drinking group:N/A

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 40-70 years old, regardless of gender; 2. Patients who meet the above definition of alcohol intolerance or the diagnostic criteria of malignant tumors with cardiovascular and cerebrovascular diseases or metabolic diseases; 3. Patients who know and voluntarily participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients; 2. Patients with severe physical diseases or severe liver and kidney dysfunction; 3. Patients with a history of mental illness.

Design outcomes

Primary

Measure	Time frame
Alcohol intolerance gene;	—

Countries

China

Contacts

Public ContactYanliu Chu

Weihai Municipal Hospital

yanliuchu@163.com+86 18615161167

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026